_2.jpg)
Xaltrin XL (Alfuzosin HCI 10mg)
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- drug, alfuzosin hydrochloride, bph treatment, pharmaceuitcals
- Category
- Pharmaceuticals
AHN-GOOK PHARMACEUTICAL CO.,LTD.
- Membership
- VIP
- Recent Visit
- Dec 23, 2024
- Country / Year Established
-
South Korea
/
1959
- Business type
- Manufacturer
- Verified Certificate
-
16
| Product name | Xaltrin XL (Alfuzosin HCI 10mg) | Certification | - |
|---|---|---|---|
| Category | Pharmaceuticals | Ingredients | - |
| Keyword | drug , alfuzosin hydrochloride , bph treatment , pharmaceuitcals | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | - |
| Supply type | - | HS code | - |
Product Information
Xaltrin XL
* Composition
- Each tablet contains 10mg alfuzosin hydrochloride
- Pharmaceutical form prolonged release tablet
- Round biconvex, filim-coated tablet
- Three layer tablet : one white layer between two yellow layers.
* Indication
- Treatment of symptoms of benign prostatic hyperplasia (BPH)
- Use in acute urinary retention (AUR) related to BPH
* Key advantages
1. A Tablet with upgraded proprietary formulation technology
2. Improved patients compliance as once a day dosing
3. The excellent therapeutic effect
4. Positive safety profile
Xaltrin XL
* Composition
- Each tablet contains 10mg alfuzosin hydrochloride
- Pharmaceutical form prolonged release tablet
- Round biconvex, filim-coated tablet
- Three layer tablet : one white layer between two yellow layers.
* Indication
- Treatment of symptoms of benign prostatic hyperplasia (BPH)
- Use in acute urinary retention (AUR) related to BPH
* Key advantages
1. A Tablet with upgraded proprietary formulation technology
2. Improved patients compliance as once a day dosing
3. The excellent therapeutic effect
4. Positive safety profile
Xaltrin XL
* Composition
- Each tablet contains 10mg alfuzosin hydrochloride
- Pharmaceutical form prolonged release tablet
- Round biconvex, filim-coated tablet
- Three layer tablet : one white layer between two yellow layers.
* Indication
- Treatment of symptoms of benign prostatic hyperplasia (BPH)
- Use in acute urinary retention (AUR) related to BPH
* Key advantages
1. A Tablet with upgraded proprietary formulation technology
2. Improved patients compliance as once a day dosing
3. The excellent therapeutic effect
4. Positive safety profile
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Eo Junseon
- Address
- yeongdeungpo-gu,613 siheung-daero, Yeongdeungpo-gu, Seoul, Korea
- Product Category
- Pharmaceuticals
- Year Established
- 1959
- No. of Total Employees
- 101-500
- Company introduction
-
Established in 1959, Ahngook has been developed to one of leading pharmaceutical corporation in Korea.
Starting from first oral form of eye-nutrient, Tobicom-S, Ahngook developmed numerous promising New drugs and Incrementally modified drugs.
Ahngook is especially strong to cardiovascular, respiratory, urology and other niche areas.
Ahnook is aggresively attending several internationl exhibitions to introduce our major products in the galobal market with the aim of becoimg a top global company.
So now, we're expanding our business network to Japan, Vietnam, Malaysia, Iran and some region of Africa and Latin countries.
- Main Markets
-
Iran
Japan
Mexico
Philippines
Viet Nam
- Main Product
_2.jpg "Anycough Cap_ _Theobromine 300mg__1")
_2.jpg "Korea Red Ginseng extract_Plus__1")
